These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 13125920)
21. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395 [TBL] [Abstract][Full Text] [Related]
22. Tetanus, diphtheria, and acellular pertussis vaccine: a position statement of the Society for Adolescent Medicine. Middleman AB; Bruner A J Adolesc Health; 2009 Sep; 45(3):316-7. PubMed ID: 19699431 [No Abstract] [Full Text] [Related]
23. Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: reassurance for the future. Halperin SA J Pediatr; 2006 Nov; 149(5):589-91. PubMed ID: 17095321 [No Abstract] [Full Text] [Related]
24. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA. Gidengil CA; Sandora TJ; Lee GM Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017 [TBL] [Abstract][Full Text] [Related]
25. Nicolau's syndrome in a newborn caused by triple DTP (diphtheria-tetanus-pertussis) vaccination. Erkek E; Tuncez F; Sanli C; Duman D; Kurtipek GS; Bagci Y; Ayaslioglu E J Am Acad Dermatol; 2006 May; 54(5 Suppl):S241-2. PubMed ID: 16631955 [No Abstract] [Full Text] [Related]
29. Routine active immunisations in paediatric practice. Jain AM J Indian Med Assoc; 1968 Nov; 51(9):452-6. PubMed ID: 5729064 [No Abstract] [Full Text] [Related]
30. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [TBL] [Abstract][Full Text] [Related]
31. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328 [TBL] [Abstract][Full Text] [Related]
32. Immunisation against diphtheria, tetanus and whooping cough in childhood. Hickling S N Z Med J; 1966 Jun; 65(406):357-62. PubMed ID: 5222031 [No Abstract] [Full Text] [Related]
33. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis. Gabutti G J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533 [No Abstract] [Full Text] [Related]
34. Immunization of children: a report on an aluminum-phosphate adsorbed triple vaccine. WATSON EH; STEWART WC Med Bull (Ann Arbor); 1952 Nov; 18(11):311-5. PubMed ID: 13015748 [No Abstract] [Full Text] [Related]
35. Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine as a single-dose booster in Singaporean adults. Chan SH; Tan PT; Han HH; Bock HL Singapore Med J; 2006 Apr; 47(4):286-90. PubMed ID: 16572239 [TBL] [Abstract][Full Text] [Related]